¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"volume modifying factor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pressure volume curve
    ¾Ð·Â¿ëÀû°î¼±
  • pressure volume relation
    ¾Ð·Â¿ëÀû°ü°è
  • packed cell volume
    ³óÃ༼Æ÷¿ëÀû, ÃæÀü¼¼Æ÷¿ëÀû
  • partial volume effect
    ºÎºÐ¿ëÀûÈ¿°ú
  • residual volume
    Àܱⷮ, ³²Àº°ø±â·®
  • stroke volume
    ÀÏȸ¹ÚÃâ·®
  • stroke volume index
    ¹ÚÃâ·®Áö¼ö
  • volume
    ºÎÇÇ, ¿ëÀû, -·®
  • volume acquisition
    ¿ëÀûȹµæ
  • volume conduction
    º¼·ýÀüµµ
  • volume dilatometer
    ºÎÇÇÆØÃ¢°è, ¿ëÀûÆØÃ¢°è
  • volume elasticity coefficient
    ¿ëÀûź·Â·ü
  • volume expander
    Ç÷·®Áõ·®Á¦
  • volume fraction
    ºÎÇǺÐÀ², ¿ëÀûºÐÀ²
  • volume gradient echo technique
    ¿ëÀû±â¿ï±â¿¡ÄÚ±â¹ý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • packed cell volume
    ÃæÀü¼¼Æ÷¿ëÀû, ³óÃ༼Æ÷¿ëÀû
  • residual volume
    Àܱⷮ, ³²Àº°ø±â·®
  • stroke volume
    ÀÏȸ¹ÚÃâ·®
  • tidal volume
    ÀÏȸȣÈí·®
  • factor
    ÀÎÀÚ, ¿äÀÎ, °è¼ö
  • activation factor
    Ȱ¼ºÀÎÀÚ
  • antiplatelet factor
    Ç×Ç÷¼ÒÆÇÀÎÀÚ
  • coagulation V factor
    Á¦5Ç÷¾×ÀÀ°íÀÎÀÚ
  • exclusion of confounding factor
    ±³¶õº¯¼ö¹èÁ¦
  • growth factor
    ¼ºÀåÀÎÀÚ
  • intrinsic factor
    ³»ÀÎÀÎÀÚ, ³»ÀÎÀÚ
  • nerve growth factor
    ½Å°æ¼ºÀåÀÎÀÚ
  • platelet activating factor
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
  • precipitation factor
    ÃËÁø¿äÀÎ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • expiratory reserve volume
    ³¯¼û¿¹ºñ·®, ¿¹ºñ³¯¼û·®
  • partial volume effect
    ºÎºÐ¿ëÀûÈ¿°ú
  • plasma volume expander
    ÀΰøÇ÷ÀåÁõ·®Á¦
  • volume expander
    Ç÷·®Áõ·®Á¦
  • forced expiratory volume
    °­Á¦³¯¼û·®, ³ë·Â³¯¼ûÆóȰ·®
  • forced inspiratory volume
    °­Á¦µé¼û·®, ³ë·Âµé¼ûÆóȰ·®
  • volume fraction
    ºÎÇǺÐÀ², ¿ëÀûºÐÀ²
  • gross tumor volume
    ¸Ç´«Á¾¾çüÀû
  • inspiratory reserve volume
    µé¼û¿¹ºñ·®, ¿¹ºñµé¼û·®
  • inspiratory triggering volume
    µé¼ûÀ¯¹ß¿ëÀû
  • stroke volume index
    ¹ÚÃâ·®Áö¼ö
  • volume index
    ºÎÇÇÁö¼ö
  • mean corpuscular volume
    Æò±ÕÀûÇ÷±¸¿ëÀû
  • mean platelet volume
    Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
  • minute volume
    ºÐ´çÈ£Èí·®, ºÐ´ç¹ÚÃâ·®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gross tumor volume, GTV
    À°¾ÈÀûÁ¾¾çüÀû
  • high volume sampler
    ÇÏÀ̺¼·ý»ùÇ÷¯.
  • inspiratory reserve volume
    Èí½Ä(¼º)¿¹ºñ¿ëÀû(ýåãÓàõçãÝáé»îÝ), Èí±âÀܱⷮ( ¡­íÑѨåÖ).
  • inspiratory triggering volume
    Èí±âÀ¯¹ß·®.
  • phonatory air volume
    ¹ß¼º½Ã°ø±â·®(¡­ãÁÍöѨåÖ).
  • planning target volume
    °èȹ¿ë Ç¥ÀûºÎÇÇ
  • plasma expander =p. volume e.
    ´ë¿ëÇöóÁ<Ç÷Àå>, ÇöóÁ<Ç÷Àå(úìíì )>Áõ·®Á¦(¡­ñòåÖð¥).
  • plasma volume
    Ç÷Àå·®(úìíìåÖ).
  • pressure volume curve
    ¾Ð·Â¿ëÀû°î¼±(äâæ³é»îÝÍØàÊ).
  • pressure volume diagram
    ¾Ð·®µµ, ¾Ð·Â¿ëÀû°î¼±.
  • pressure volume relation
    ¾Ð·Â¿ëÀû°ü°è.
  • red cell volume
    ÀûÇ÷±¸¿ëÀû(îåúìϹ é»îÝ).
  • red corpuscle volume
    ÀûÇ÷±¸¿ëÀû(îåúìϹé»îÝ).
  • relative osteoid volume
    »ó´ëÀû À¯°ñ·®
  • AHF=£¾antihemophilic factor
    Ç×Ç÷¿ìÀÎÀÚ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cardiac minute output =c. m. volume, c. output per minute
    ¸ÅºÐ(½É)¹ÚÃâ·®(ØßÝÂãýÚÑõóåÖ).
  • cardiac minute volume
    ¸ÅºÐ(½É)¹ÚÃâ·®
  • cardiac volume
    ½ÉÀå¿ëÀû(ãýíôé»îÝ)
  • circulating blood volume
    ¼øÈ¯Ç÷¾×·®(âàü»úìäûåÖ).
  • clinical target volume, CTV
    ÀÓ»óÇ¥ÀûüÀû
  • closing volume
    Æó¼â¿ëÀû.
  • closing volume
    Æó¼â¿ëÀû.
  • complementary air =inspiratory reserve volume
    ¿¹ºñÈí±â·®(çãÝáýåѨåÖ) .
  • corpuscular volume
    ÀûÇ÷±¸(îåúìϹ)(°³°³ÀÇ) üÀû(¡­ô÷îÝ).
  • corpuscular volume
    ÀûÇ÷±¸(°³°³ÀÇ) üÀû(?Ì§Ëø).
  • diastolic volume
    È®Àå±â¿ëÀû(¡­é»îÝ).
  • dose-volume histogram, DVH
    ¼±·®Ã¼ÀûÈ÷½ºÅä±×¶÷
  • dose-volume histograms
    ¼±·®Ã¼ÀûÇ¥
  • effective blood volume
    À¯È¿Ç÷¾×·®(êóüùúìäûÕá).
  • effective blood volume
    À¯È¿Ç÷¾×·®.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acetate-replacing factor
    ¾Æ¼¼Æ®»ê(ß«)ġȯ ÀÎÀÚ(öÇüµì×í­)
  • achromotrichia factor
    ¸ð¹ß»ö¼Ò°áÇÌÀÎÀÚ (Ù¾Û¥ßäáÈÌÀù¹ì×í­)
  • angiogenic factor
    Ç÷°üÇü¼ºÀÎÀÚ(úìηû¡à÷ì×í­)
  • animal protein factor
    µ¿¹°´Ü¹éÁúÀÎÀÚ(ÔÑÚªÓ±ÛÜòõì×í­)
  • anti-egg-white injury factor
    Ç׳­¹é ¼Õ»óÀÎÀÚ(ù÷ÑëÛÜáßß¿ì×í­)
  • anti-fatty-liver-factor
    Ç×Áö¹æ°£ÀÎÀÚ(ù÷ò·Û¸ÊÜì×í­)
  • anti-gray-hair factor
    Ç×¹é¸ð¹ß ÀÎÀÚ(ù÷ÛÜÙ¾Û¥ì×í­)
  • antiacrodynia factor
    Ç×Áö´Üµ¿Åë ÀÎÀÚ(ù÷ò¶Ó®ÔÙ÷Ôì×í­)
  • antianemia factor
    Ç׺óÇ÷ÀÎÀÚ(ù÷Þ¸úìì×í­)
  • antiberiberi factor
    Ç×°¢±âÀÎÀÚ(ù÷ÊÅѨì×í­)
  • antiblack-tongue factor
    Ç×Èæ¼³ÀÎÀÚ(ù÷ýÙàßì×í­)
  • antihemophilic factor
    Ç×Ç÷¿ìº´ÀÎÀÚ(ù÷úìéÒÜ»ì×í­)
  • antihemophilic factor B
    Ç×Ç÷¿ìº´ÀÎÀÚ (ù÷úìéÒÜ»ì×í­) B
  • antihemophilic factor C
    Ç×Ç÷¿ìº´ÀÎÀÚ (ù÷úìéÒÜ»ì×í­) C
  • antineuritic factor
    Ç׽Ű漺ÀÎÀÚ(ù÷ãêÌèàõì×í­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • respiratory volume
    È£Èí¿ëÀû
  • sample volume
    Ç¥º»¿ëÀû
  • stroke volume
    (ÀÏȸ)¹ÚÃâ·®
  • tidal volume
    ÀÏÈ£Èí·®, ÀÏÈ£Èí¿ëÀû
  • volume
    ºÎÇÇ, ¿ëÀû, ¡ìÃ¥ÀÇ¡í±Ç
  • volume acquisition
    ¿ëÀûȹµæ
  • volume averaging effect
    ¿ëÀûÆò±ÕÈ­È¿°ú
  • volume coil
    ¿ëÀûÄÚÀÏ
  • volume element = voxel
    È­Àû¼Ò
  • volume gradient echo technique
    ¿ëÀû°æ»ç¿¡ÄÚ±â¹ý
  • volume magnetic susceptibility
    ¿ëÀûÀÚÈ­À²
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PAF paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl...
SF Sabin-Feldman [test]; safety factor; salt-free; scarlet fever; screen film; seminal fluid; serosal f...
TF free thyroxine; tactile fremitus; tail flick [reflex]; temperature factor; testicular feminization; ...
DMARDs Disease Modifying Anti-Rheumatic Drugs
DMARD disease-modifying anti-rheumatic drug
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FVIII-vWF Factor VIII-von Willebrand Factor
Factor Xa Factor X
GM-CSF Granulocyte colony-stimulating factor , granulocyte-macrophage colony-stimulating factor
G-CSF Granulocyte-Macrophage Colony-Stimulating Factor , Granulocyte Colony-Stimulating Factor
HB-EGF Heparin binding epidermal growth factor-like growth factor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • forced expiratory volume
    °­Á¦ È£±â·®, °­Á¦ ÆóȰ·®, ³ë·Â È£±â ÆóȰ·®
  • left ventricular end-diastolic volume
    Á ½É½Ç À̿ϱ⸻ ¿ëÀû
  • mean cell volume
    Æò±Õ ÀûÇ÷±¸ ¿ëÀû
  • mean corpuscular volume
    ÀûÇ÷±¸ÀÇ Æò±Õ ¿ëÀû, Æò±Õ ÀûÇ÷±¸ ¿ëÀû
    MCV´Â ÀûÇ÷±¸ ÇÑ °³ ÇÑ °³ÀÇ Æò±Õ ¿ëÀûÀ» ¥ì3À¸·Î Ç¥½ÃÇÑ °Í.
  • molar volume
    ¸ô ºÎÇÇ
  • packed cell volume
    ÃæÀü ¼¼Æ÷ ¿ëÀû
  • parital volume averaging artifact
    ºÎºÐ ¿ëÀû Æò±Õ Àΰø¹°
  • partial volume averaging
    ºÎºÐ ¿ëÀû Æò±ÕÈ­
  • partial volume imaging
    ºÎºÐ ¿ëÀû ¿µ»ó
  • pore volume
    ±â°ø ºÎÇÇ
  • red cell volume
    ÀûÇ÷±¸ ¿ëÀû
    ü³»ÀÇ ÃÑÀûÇ÷±¸ ¿ë·®À¸·Î¼­ ¹æ»ç´É µ¿À§¿ø¼Ò·Î ÃøÁ¤ÇÑ´Ù.
  • relative osteoid volume
    »ó´ëÀû À¯°ñ·®
  • stroke volume
    ¹ÚÃâ·®
  • volume
    ºÎ, ¿ë, üÀû, Å©±â
    ¹°ÁúÀÇ ¾ç, ¶Ç´Â ¿ëÀûÀÇ Å©±â.
  • volume conductor
    ÀÔüÀû µµÃ¼
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
volume index An indication of the relative size (e.g., volume) of erythrocytes, calculated as follows: haematocrit value, expressed as per cent of normal &divide; red blood cell count, expressed as per cent of normal = volume index.
(05 Mar 2000)
volume loading rate The rate of raw materials put into a fermenter or aerobic digester, expressed in terms of material weight per unit volume per unit time.
(09 Oct 1997)
volume substitute Infusion of cell-free or volume-expanding fluids such as dextran for replacement of fluid lost from the circulation as part of the prevention or treatment of circulatory shock.
(05 Mar 2000)
volume unit A unit of a logarithmic scale for expressing the power level of a complex audio-frequency electrical signal, such as that transmitting music or speech; the power in volume unit's equals the decibels of power above a reference level of one milliwatt, as measured with an appropriate meter.
(05 Mar 2000)
respiratory minute volume The minute volume of breathing; the product of tidal volume times the respiratory frequency.
See: pulmonary ventilation.
(05 Mar 2000)
resting tidal volume The tidal volume under normal conditions, i.e., in the absence of exercise or other conditions that stimulate breathing.
(05 Mar 2000)
right ventricular volume overload <radiology> Atrial septal defect, partial/total APVR, tricuspid insufficiency, pulmonary insufficiency, congenital/aquired absence of pericardium, Ebstein anomaly (not truly RV)
(12 Dec 1998)
minute volume The volume of any gas or fluid moved per minute; e.g., cardiac output or the respiratory minute volume.
(05 Mar 2000)
closing volume The lung volume at which the dependent lung zones cease to ventilate presumably as a result of airway closure.
(12 Dec 1998)
plasma volume Volume of plasma in the circulation. It is usually measured by indicator dilution techniques.
(12 Dec 1998)
pressure-volume index Method of evaluating the cerebrospinal fluid hydrodynamics.
(05 Mar 2000)
specimen interaction volume <microscopy> The volume inside the specimen in which all specimen interactions occur during electron beam irradiation.
(05 Aug 1998)
standard volume The volume of an ideal gas at standard temperature and pressure, approximately 22.414 liters.
(05 Mar 2000)
stroke volume <physiology> The amount of blood pumped out of one ventricle of the heart as the result of a single contraction. A measure of the effectiveness of ventricular contraction.
(16 Dec 1997)
distribution volume The volume throughout which an added tracer substance appears to have been evenly distributed, calculated by dividing the amount of tracer added by its concentration after equilibration.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nerve growth factor
    (»ý¸®)½Å°æ ¼ºÀåÀÎÀÚ(Áö°¢(±³°¨)½Å°æ¼¼Æ÷ÀÇ ¼ºÀåÀ» ÀÚ±ØÇÏ´Â ´Ü¹éÁú)
  • noise factor(figure)
    (ÁõÆø±â¿¡¼­ÀÇ)ÀâÀ½Áö¼ö
  • pp factor
    Ç× Æç¶ó±×¶ó ÀÎÀÚ(Æç¶ó±×¶ó ¿¹¹æ¿¡ ¾²´Â ´ÏÄÚÆ¾»ê,´ÏÄÚÆ¾»ê¸¶À̵å)
  • prime factor
    ¼ÒÀμö
  • releasing factor
    È£¸£¸ó ¹æÃâÀÎÀÚ
  • rheumatoid factor
    ·ù¸ÓƼÁòÀÎÀÚ(¸¸¼º °üÀý ·ù¸ÓƼÁò ȯÀÚÀÇ ÀÚ±â Ç×ü)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á